Global CMO/CDMO Market Size study, by Service (Contract Development, Contract Manufacturing), by Product (Hair Products, Skin Products, Lip Products, Eye Products, Body hygiene, Oral hygiene) and Regional Forecasts 2021-2027

Global CMO/CDMO Market is valued at approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2021-2027. CMO/CDMO are companies that take a pre-formulated drug and manufacture it, while CDMOs are companies that do both the development and manufacturing of a drug. Rising demand for face care creams, sunscreen lotions and need for state-of-the-art processes and production technologies has led to the adoption of CMO/CDMO across the forecast period. For Instance: According to Axios, a prominent online news company in the United States, as of 2018, pharmaceutical industries in the country had the tenth-highest average after-tax profit levels, when compared to more than 100 different industries. While drug companies are responsible for 23% of the US health revenue, they also make 63% of the total profits. Also, with the growing demand for generic medicines and biologics, the adoption & demand for CMO/CDMO is likely to increase the market growth during the forecast period. However, government regulations impede the growth of the market over the forecast period of 2021-2027.

The key regions considered for the global CMO/CDMO market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading region across the world in terms of market share owing to the massive investments and facility expansion, mergers and acquisitions. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to presence of the major supplier of the raw materials required or the beauty and personal care product manufacturing would create lucrative growth prospects for the CMO/CDMO market across Asia-Pacific region.

Major market players included in this report are:
Samriddhi Life Sciences
 Chemineau, C.O.C.
Farmaceutici Srl
Paragon Nordic
Cosmetic Solutions
Kolmar 
Lonza
Cho Chuang Industrial Co., Ltd.
Vive Cosmetics
Ori BioNature Sdn Bhd
Zoic Cosmetics

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. 

The detailed segments and sub-segment of the market are explained below: 
By Service:
Contract Development
Contract Manufacturing 

By Product:
Hair Products
Skin Products
Lip Products
Eye Products
Body hygiene
Oral hygiene

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia 
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global CMO/CDMO Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors